logo
Select company
Select metric
$ 8.36MNet Cash Flow - Financing
VS
Market
35
Sector
46
Industry
56
History
-
$ 1.21Close
$ 0.45 - $ 2.21 52-Week Range
Ticker Information

Ticker

KAPA

Company Name

KAIROS PHARMA LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

KAIROS PHARMA LTD - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KAPA - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 8.36M
3/31/2025$ 8.28M
12/31/2024$ 5.13M
9/30/2024$ 5.2M
12/31/2023$ -425K
12/31/2022$ 717K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KAIROS PHARMA LTD's latest trailing twelve months (TTM) CF - Financing stands at $ 717K.
  • Over the past 5 years, KAIROS PHARMA LTD's average CF - Financing has been $ 4.54M.
  • The median CF - Financing for KAIROS PHARMA LTD during this period was $ 5.17M
  • KAIROS PHARMA LTD reached its highest CF - Financing over the past 5 years at $ 8.36M.
  • The lowest CF - Financing recorded by KAIROS PHARMA LTD in the same timeframe $ -425K

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

KAPA - Net Cash Flow - Financing, Last 5 years

$ -425K

Minimum

Dec 31, 2023

$ 8.36M

Maximum

Jun 30, 2025

$ 4.54M

Average

$ 5.17M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.27M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.27M